Active GI Research

Faculty PI

IRB

Project Title

Bloomfeld 

IRB00004422

A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects with Moderately to Severely Active Crohn's Disease (CD)

Bloomfeld 

IRB00023692

A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA (Adalimumab) in Patients with Moderately to Severely Active Ulcerative Colitis

Bloomfeld

IRB00032248

Phase II Study of ABT-494 for the Induction of Clinical Remission in Subjects with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant to Anti-TNF Therapy

Bloomfeld

IRB00032240

Open Label Vedolizumab in the Assessment of Mucosal Healing (60% TNF antagonist naïve) in Subjects With Moderately to Severely Active Crohn’s Disease Treated With Vedolizumab IV

Bonkovsky

IRB00033578

Natural History Study of Acute Hepatic Porphyria (AHP) Patients with Recurrent Attacks 

Bonkovsky

IRB00032089

Longitudinal Study of the Porphyrias

Bonkovsky

IRB00035104

Erythropoietic Protoporphyrias:  Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact

Bonkovsky

IRB00032089

A Multi-Center, Longitudinal Study of Drug and CAM-Induced Liver Injury

Evans

IRB00027827

Evaluation of the Effectiveness of the EVOLUTION Biliary Stent

Evans

IRB00013737

A prospective study evaluating the role of EUS prior to ERCP in the setting of “positive” intraoperative cholangiogram during cholecystectomy

Evans

IRB00027058

The Use of Pentax Endoscope Filter Technology (i-scan™) in Improving Gastroenterology Fellows’ Ability to Successfully Identify Landmarks and Cannulate the Major Duodenal Papilla during Endoscopic Retrograde Cholangiopancreatography

Koch

IRB00021176

Where is your nausea?

Koch

IRB00003537

Enterra therapy (gastric electrical stimulation) for the treatment of gastroparesis refractory to medical therapy

Koch

IRB00013932

Aprepitant for the Relief of Nausea in Patients with Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial

Koch

IRB00003135

Understanding the Pathological Basis of Gastroparesis and Identification of the Molecular Factors Involved in its Pathogenesis

Koch

IRB00020541

Continuation of the NIDDK Gastroparesis Registry for the Characterization and Clinical Course of Gastroparesis Patients

Koch

IRB00006003

Nortriptyline for Idiopathic Gastroparesis

Koch

IRB00002864

Diagnostic performance of electrogastrography (EGG) and the water load test (WLT) as screening tests for gastroparesis

Koch

IRB00032692

A Phase 2b-Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients with Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis

Mishra

IRB00000215

Utilization of EndoPro™ Database for Endoscopic Research

Weinberg

BG99-332

Structure and function of human apolipoprotein A-IV 

Weinberg

IRB00016376

Intestinally Targeted Therapies for Metabolic Syndrome, Diabetes, and Obesity

Weinberg

IRB00018035

Pharmacologic Enhancement of Laparoscopic Assisted Gastric Banding for Treatment of Obesity and the Metabolic Syndrome

Weinberg

IRB00023743

Dietary Cholesterol and Adipose Tissue Inflammation

Weinberg

IRB00020893

Neuro-Enteric Taste Signaling by a Naturally Occurring Bitter Food

Last Updated: 07-18-2016
Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.